Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Novo Nordisk A/S/ 20-F

SEC Filing · 20-F

Novo Nordisk A/S

SEC Filing

Filed Jan 31, 2024Accepted Jan 31, 2024, 6:51 AM ESTCIK 353278Accession 0001628280-24-002635
View company →Permanent SEC source ↗
Share

Company context

Current securities

NONOFOTC · EQUITY · CurrentNVONYSE · EQUITY · Current

Recent company filings

  1. 6-K filingSep 21, 2026
  2. 6-K filingSep 17, 2026
  3. 6-K filingSep 15, 2026
  4. 6-K filingSep 9, 2026
  5. 6-K filingAug 31, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗